SIBO is a measurable bacterial overgrowth in the small intestine confirmed by a breath test, while IBS is a symptom-based diagnosis of exclusion with no definitive diagnostic test. Research shows up to 78% of IBS patients test positive for SIBO, suggesting most IBS cases may have an identifiable, treatable cause. The critical difference: IBS is managed as a chronic condition (fiber, antispasmodics, diet), while SIBO can be actively treated and resolved with antimicrobials (rifaximin or herbal protocols) followed by prokinetics to prevent recurrence. If you have been diagnosed with IBS and standard treatments provide only partial relief, a SIBO breath test should be your next step.
What Is IBS, Exactly?
Irritable Bowel Syndrome is a functional gastrointestinal disorder. "Functional" is medical-speak for "we can see something is wrong, but we can't find structural damage or a clear cause." It's diagnosed using the Rome IV criteria, which essentially say: you have recurring abdominal pain at least one day per week for the past three months, associated with changes in stool frequency or form. There's no blood test, no imaging, no biopsy. IBS is a diagnosis of exclusion, which means your doctor rules out other conditions and then calls what's left IBS.
IBS comes in three main subtypes. IBS-D (diarrhea-predominant), IBS-C (constipation-predominant), and IBS-M (mixed, alternating between both). This subtype classification matters more than most people realize, because each maps surprisingly well to different types of gut overgrowth.
What Is SIBO and How Is It Different?
SIBO, Small Intestinal Bacterial Overgrowth, is a specific, measurable condition where bacteria that normally live in your large intestine have migrated into your small intestine and multiplied. Unlike IBS, SIBO has a clear mechanism: those misplaced bacteria ferment food in the wrong place, producing gases that cause bloating, pain, diarrhea or constipation, and nutrient malabsorption. SIBO is diagnosed with a lactulose or glucose breath test that measures hydrogen and methane gases, or through a jejunal aspirate (a culture taken directly from the small intestine during endoscopy).
| Feature | IBS | SIBO |
|---|---|---|
| Type of diagnosis | Symptom-based (Rome IV criteria) | Test-based (breath test or aspirate) |
| Known cause | No single known cause | Bacterial overgrowth in small intestine |
| Objective testing | None â diagnosis of exclusion | Lactulose/glucose breath test, jejunal aspirate |
| Treatment goal | Manage symptoms long-term | Eradicate overgrowth, address root cause |
| Common treatments | Fiber, antispasmodics, diet changes | Antibiotics (rifaximin), herbal antimicrobials, diet |
| Recurrence | Considered chronic | Can recur, but treatable each time |
| Subtypes | IBS-D, IBS-C, IBS-M | Hydrogen-dominant, methane-dominant (IMO), hydrogen sulfide |
The 78% Overlap: Why So Many IBS Patients Have SIBO
A landmark meta-analysis by Dr. Mark Pimentel's team at Cedars-Sinai found that SIBO is present in 38-78% of IBS patients, depending on the testing method used. The glucose breath test catches fewer cases (around 38%) because glucose gets absorbed in the upper small intestine before reaching the bacteria further down. The lactulose breath test, which travels the full length of the small intestine, catches more. Either way, the numbers are staggering. If you're one of the millions diagnosed with IBS, there's a meaningful chance you have a treatable bacterial overgrowth that nobody has tested you for.
How IBS Subtypes Map to SIBO Types
This is where things get really interesting. The type of gas produced by your overgrown bacteria directly determines your symptom pattern. Hydrogen-dominant SIBO tends to cause diarrhea, mapping closely to IBS-D. Methane-dominant overgrowth (now called IMO, Intestinal Methanogen Overgrowth) slows gut motility and causes constipation, mapping to IBS-C. And hydrogen sulfide SIBO, which we're just beginning to understand thanks to the trio-smart breath test, has been associated with both diarrhea and visceral hypersensitivity. Mixed gas patterns often correspond to IBS-M. This isn't coincidence. It's the same underlying condition being described from two different perspectives.
IBS Subtype to SIBO Type Mapping
- IBS-D (diarrhea) maps to hydrogen-dominant SIBO â bacteria produce hydrogen gas, which speeds up transit time
- IBS-C (constipation) maps to IMO (methane) â archaea produce methane, which slows gut motility by up to 59%
- IBS-M (mixed) often maps to mixed hydrogen and methane, or alternating dominance
- Hydrogen sulfide SIBO is an emerging category linked to diarrhea and visceral pain
Post-Infectious IBS: When Food Poisoning Starts It All
Here's a piece of the puzzle that changed everything: post-infectious IBS. Research from Dr. Pimentel's lab demonstrated that a single bout of food poisoning can trigger an autoimmune response where your body produces antibodies against vinculin, a protein critical for the migrating motor complex (MMC). The MMC is the cleansing wave your gut makes between meals to sweep bacteria down into the large intestine. When anti-vinculin antibodies damage this mechanism, bacteria accumulate in the small intestine. Food poisoning leads to autoimmune damage, which leads to impaired motility, which leads to SIBO, which gets diagnosed as IBS. The chain is clear, testable (via the ibs-smart blood test for anti-vinculin and anti-CdtB antibodies), and increasingly accepted in gastroenterology.
âšī¸The ibs-smart test measures anti-vinculin and anti-CdtB antibodies in your blood. A positive result strongly suggests your IBS symptoms have a post-infectious origin and that impaired gut motility is driving bacterial overgrowth. This test can help differentiate IBS from IBD and other conditions.
The Rome IV Criteria: Useful but Incomplete
The Rome IV criteria serve an important purpose. They give doctors a standardized framework for identifying functional GI disorders when no structural cause is found. But the criteria don't ask about SIBO. They don't require breath testing. They don't look for motility disorders, post-infectious autoimmunity, or fungal overgrowth. A patient can meet every Rome IV criterion for IBS while having a completely treatable bacterial overgrowth. The criteria identify the pattern but not the cause. That's the gap, and it's the reason so many SIBO patients spend years rotating through fiber supplements, antispasmodics, and coping strategies without improvement.
Why the Distinction Changes Your Treatment
Standard IBS treatment focuses on symptom management: dietary modifications (often low-FODMAP), antispasmodics like hyoscyamine or dicyclomine, fiber for IBS-C, loperamide for IBS-D, and sometimes antidepressants for visceral pain modulation. These can help you cope, but they don't address bacterial overgrowth. SIBO treatment targets the root cause. Rifaximin (Xifaxan) is the most-studied antibiotic, with a 2-week course eradicating SIBO in about 50% of cases. For methane-dominant cases, rifaximin plus neomycin or metronidazole significantly improves success rates. Herbal antimicrobials like berberine, oregano oil, and neem have shown comparable efficacy to rifaximin in a Johns Hopkins study. After treatment, prokinetics and dietary strategies help prevent recurrence.
How to Talk to Your Doctor About SIBO Testing
Not every gastroenterologist is up to speed on the SIBO-IBS connection. If you've been managing IBS for months or years without improvement, here's how to advocate for yourself. Start by saying something like: "I've been reading about the overlap between IBS and SIBO, and I'd like to rule out bacterial overgrowth with a lactulose breath test." Framing it as "ruling out" rather than self-diagnosing tends to land better. If your doctor pushes back, mention that the American College of Gastroenterology's 2021 guidelines acknowledge SIBO breath testing as appropriate for IBS patients with persistent symptoms. You can also ask about the ibs-smart test to check for post-infectious markers. If your current provider isn't willing to investigate, a functional medicine doctor or SIBO-literate GI specialist may be worth consulting.
Conversation Starters for Your Doctor
- "Could we do a lactulose breath test to rule out SIBO?"
- "I've had IBS symptoms for [time] and I'm not improving. I'd like to explore whether bacterial overgrowth could be contributing."
- "I had a food poisoning episode before my symptoms started. Could we check for post-infectious IBS with the ibs-smart test?"
- "I've noticed my bloating is worse with specific carbohydrates, which makes me wonder about fermentation in the small intestine."
The Treatment Paradigm Shift
Gastroenterology is in the middle of a quiet revolution. The old model said IBS is a chronic, idiopathic condition and your job is to manage it. The new model recognizes that a large percentage of IBS cases have identifiable, treatable causes: SIBO, IMO, SIFO, bile acid malabsorption, post-infectious autoimmunity, and motility disorders. This shift doesn't mean IBS doesn't exist. Some patients genuinely have functional symptoms without any identifiable overgrowth or structural cause. But the number of patients who fall into that category shrinks every year as our testing and understanding improves. If you have IBS and haven't been tested for SIBO, you owe it to yourself to investigate.
đĄTracking your symptoms alongside your meals and bowel movements can help your doctor distinguish between IBS and SIBO. GLP1Gut makes this easy with symptom-meal correlation tracking, so you show up to your appointment with actionable data instead of vague descriptions.
Frequently Asked Questions
Is SIBO the same as IBS?
No. IBS is a syndrome, a collection of symptoms (bloating, abdominal pain, altered bowel habits) that meet the Rome IV diagnostic criteria. SIBO is a specific condition where bacteria overgrow in the small intestine, producing gases that cause symptoms. The confusion exists because SIBO symptoms almost perfectly mimic IBS symptoms. Studies show 38-78% of people diagnosed with IBS actually have SIBO. Think of it this way: IBS describes what you're experiencing, while SIBO explains why it's happening. The critical difference is that SIBO is treatable with targeted antibiotics or herbal antimicrobials, whereas IBS treatment focuses on managing symptoms indefinitely. Getting tested for SIBO could change your treatment plan entirely.
Can IBS be caused by SIBO?
Yes, and this is one of the most important developments in gastroenterology in the past two decades. SIBO can cause all the hallmark symptoms of IBS: bloating, gas, abdominal pain, diarrhea, and constipation. When bacteria in the small intestine ferment carbohydrates, they produce hydrogen and methane gases that directly cause these symptoms. Dr. Mark Pimentel's research at Cedars-Sinai has been instrumental in establishing this connection. His team showed that treating SIBO with rifaximin improved IBS symptoms significantly in multiple large-scale clinical trials, which is how rifaximin became the first FDA-approved antibiotic for IBS-D. The takeaway: SIBO doesn't just mimic IBS. In many cases, SIBO is the underlying cause of what gets labeled as IBS.
How do I know if my IBS is actually SIBO?
The only definitive way is testing. A lactulose breath test is the most accessible option. You drink a lactulose solution, then breathe into collection tubes every 15-20 minutes for about 3 hours. The lab analyzes hydrogen, methane, and sometimes hydrogen sulfide levels. A rise in hydrogen or methane before the 90-minute mark (when the solution reaches your large intestine) suggests bacterial overgrowth in the small intestine. Red flags that your IBS might be SIBO include: symptoms that started after food poisoning, bloating within 30-60 minutes of eating, symptoms that worsen with prebiotics or probiotics, and persistent symptoms despite following a low-FODMAP diet. Your doctor can order the breath test, or you can request one through a functional medicine provider.
Can treating SIBO cure my IBS?
For many people, yes. Multiple studies have shown that successful SIBO treatment leads to significant or complete resolution of IBS symptoms. The TARGET 3 trial, a large randomized controlled trial, found that rifaximin provided lasting IBS symptom relief in a meaningful percentage of patients. However, "cure" is complicated with SIBO because recurrence rates are notable, roughly 40-50% within 9 months if the underlying cause of the overgrowth isn't addressed. That means treating SIBO is often not a one-and-done situation. You need to identify and address what allowed the overgrowth in the first place, whether that's impaired motility, adhesions, low stomach acid, or something else. Post-treatment prokinetics and dietary strategies are key to staying in remission.
What is post-infectious IBS?
Post-infectious IBS (PI-IBS) develops after an acute episode of gastroenteritis, what most people call food poisoning. The infecting bacteria release a toxin called CdtB, and your immune system produces antibodies against it. Unfortunately, those antibodies cross-react with vinculin, a protein in your gut's nerve cells that helps control the migrating motor complex (MMC). The MMC is the housekeeping wave that sweeps bacteria out of your small intestine between meals. When anti-vinculin antibodies damage this system, bacteria accumulate and SIBO develops. PI-IBS accounts for an estimated 10-15% of all IBS cases. The ibs-smart blood test can detect anti-CdtB and anti-vinculin antibodies, giving you and your doctor clear evidence that your symptoms have a post-infectious, autoimmune origin.
â ī¸This article is for educational purposes only and is not a substitute for professional medical advice. SIBO and IBS require proper diagnosis and treatment by a qualified healthcare provider. Do not stop or change any medication without consulting your doctor.